Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects.
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.
Transplantation of Human Adipose-Derived Stem Cells Enhances Remyelination in Lysolecithin-Induced Focal Demyelination of Rat Spinal Cord.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.
Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.
The gut microbiota and its correlations with the central nervous system disorders.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Multiple Sclerosis in Children.
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.
FDA approval of Isentress (raltegravir)
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
T Cell-Intrinsic Function of the Noncanonical NF-κB Pathway in the Regulation of GM-CSF Expression and Experimental Autoimmune Encephalomyelitis Pathogenesis.

Pages